Summary
I am a full-time, EPSRC Deans award funded (within the STRATiGRAD doctoral programme) PhD student at the Department of Surgery and Cancer, supervised by Prof Elaine Holmes and co-supervised by Prof Bill Wisden. I am also part of Holme's group in the UK Dementia Research Institute at Imperial.
My current research focuses on utilising metabolomics for understanding the pathogenesis and neurodegenerative diseases and identifying potential biomarkers, specifically for Alzheimer’s disease (AD). I am also investigating the link between sleep deprivation and circadian disruption in relation to AD.
Prior to starting my PhD, I graduated with a BSc(Hons) in Medical Biochemistry at Royal Holloway University of London (2014) investigating unknown proteins associated with NMDA receptors. Shortly after, I completed my MSc in Clinical Neuroscience at King's College London (2016) where I conducted research into novel oral drugs purposed for Multiple Sclerosis and received a Gold Medal Award by the Programme Board Chair. Finally, I worked as a Clinical Research Assistant at the Clinical Research Centre at the University of Surrey (2017-2018) where I contributed to ongoing clinical trials (phase I - IV).
Excessive reservations and paralyzing despondency have not helped the sciences to advance nor are they helping them to advance, but a healthy optimism that cheerfully searches for new ways to understand, as it is convinced that it will be possible to find them Alois Alzheimer Physician